Loading...
Olsalazine is not superior to placebo in maintaining remission of inactive Crohn's colitis and ileocolitis: a double blind, parallel, randomised, multicentre study
BACKGROUND AND AIMS—The benefit of 5-aminosalicylic acid therapy for maintenance of remission in Crohn's disease is controversial. The primary aim of this study was to evaluate the prophylactic properties of olsalazine in comparison with placebo for maintenance of remission in quiescent Crohn&#...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2001
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1728458/ https://ncbi.nlm.nih.gov/pubmed/11559654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.49.4.552 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|